FIELD: organic chemistry, medicine. SUBSTANCE: invention concerns the use of sulfosubstituted metal free phthalocyanine and its magnesium complex of the general formula (I) as a photosensitizing agent for photodynamic therapy. Indicated phthalocyanines are the more effective photosensitizing agents in the process of photodynamic therapy carrying out. EFFECT: enhanced effectiveness of compounds. 3 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
TETRAAZACHLORINES AS PHOTOSENSIBILIZATORS FOR PHOTODYNAMIC THERAPY | 2004 |
|
RU2278119C1 |
METHOD OF DETERMINING FRACTIONAL COMPOSITION OF SULPHONATED ALUMINUM PHTHALOCYANINE | 2019 |
|
RU2720799C1 |
PHOTOSENSIBILIZING AGENT, LIPOSOMAL FORMULATION OF PHOTOSENSIBILIZING AGENT AND METHOD FOR CARRYING OUT PHOTODYNAMIC THERAPY | 2004 |
|
RU2257898C1 |
ALKYLTHIOSUBSTITUTED PHTALOCYANIDES, THEIR MEDICINAL FORMS AND METHOD OF PHOTODYNAMIC THERAPY | 2007 |
|
RU2340615C1 |
MEANS AND METHOD FOR APPLYING PHOTODYNAMIC THERAPY | 2004 |
|
RU2271801C2 |
BIOTISSUE PHANTOM AND INDICATOR FOR PHOTOSENSITIZER'S CONTENT | 2001 |
|
RU2210315C2 |
PHOTOSENSITIZING AGENTS FOR PHOTODYNAMIC THERAPY | 2005 |
|
RU2282646C1 |
METHOD FOR MODIFYING PHOTODYNAMIC THERAPY | 2010 |
|
RU2449821C1 |
METHOD FOR LOCAL INTRODUCTION OF PREPARATIONS IN CASE OF HEPATIC TUMORS | 2000 |
|
RU2200479C2 |
PHOTOSENSITISERS FOR PHOTODYNAMIC THERAPY | 2013 |
|
RU2536966C1 |
Authors
Dates
2002-06-20—Published
1999-11-26—Filed